Former Shreveport, Louisiana Medical Practitioner Sentenced to 36 Months

SHREVEPORT, LA – Larry Clyde Daniels, 65, of Keithville, Louisiana, was sentenced on November 29, 2023, for distribution of controlled substances outside the bounds of professional medical practice to 36 months followed by three years of supervised release and a $20,000.00 fine by United States District Judge Elizabeth E. Foote announced United States Attorney Brandon B. Brown.

On December 16, 2020, Larry Clyde Daniels, 65, of Keithville, Louisiana, was charged in an 82-count Indictment for violations of Distribution of Controlled Substances—buprenorphine, a Schedule III controlled substance, Klonopin, a Schedule IV controlled substance, and Adderall, a Schedule I controlled substance—outside the bounds of professional medical practices.

Daniels pled guilty to Count 44 and on November 29, 2023, Daniels was sentenced by Judge Elizabeth E. Foote to 36 months in federal prison, three years supervised release, and a $20,000.00 fine for distribution of controlled substances outside the bounds of professional medical practice.

“It is no secret that many Americans suffer from opioid addiction and the effects can be fatal,” said U.S. Attorney Brandon B. Brown.  Physicians, by way of their oath, undertake a great responsibility to exhaust all efforts to ensure that those who are prescribed opioids actually need them.  This defendant admittedly failed to do so by over prescribing these powerful drugs.  We hope this sentence sends a powerful message to physicians who consider engaging in such conduct.”

From 2016 through 2017, Daniels was a medical practitioner practicing within the Western District of Louisiana. Daniels received a Drug Addiction Treatment Act waiver in 2007 and was authorized to treat patients with opioid addictions. Daniels worked one night a week from 6:00pm to 8:00pm at the Warren Medical Multi-Care Clinic. On September 12, 2017, an undercover DEA agent acting as a patient, paid $325.00 in cash for the first visit with Daniels and was requested to come back the following evening to see Daniels.

The next day the undercover agent met with Daniels for approximately eight minutes. After this meeting, Daniels prescribed the undercover agent buprenorphine with a starting dose in excess of what is required without documenting a rationale for such starting dosage in the undercover’s patient file. Also, Daniels noted that the undercover relayed a history of recreational drug abuse but failed to discuss with the undercover the negative results of his drug test and failed to perform a physical examination. As a result, Daniels’ actions violated acceptable medical practices and acceptable medical practices within the State of Louisiana.

The Drug Enforcement Administration conducted the investigation and Assistant U.S. Attorneys Tennille M. Gilreath and Allison Duncan prosecuted the case.